logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Market Shift | CICC (03908.HK) Soars More Than 4%, JP Morgan Predicts that the Company's H Shares May Outperform A Shares in the Short Term. Potential Mergers and Acquisitions News Could Be a Catalyst.

date
20/12/2025
According to the Intelligence Finance APP, Zhongjin Company (03908.HK) surged more than 4%, as of the time of writing, rose by 4.01%, to 20.22 Hong Kong dollars, with a turnover of 406 million Hong Kong dollars.
Latest
13 m ago
Trump Media's nuclear fusion partner faces debt accusations.
17 m ago
Overnight news summary on December 20th.
20 m ago
Fitch Ratings: Due to the fiscal deficit, it is estimated that the ratio of Gabon government debt to GDP will further rise to 85.5% by 2026, and to 86.7% by 2027. Affected by the reduction in government spending under financing pressure, it is expected that the country's economic growth rate will slow down to 2.7% from 2026 to 2027.
25 m ago
Flanigan's Enterprises (BDL.US): Q4 2025 financial report achieved revenue of $49.19 million, up from $46.01 million; earnings per share were $0.48, up from $0.10.
29 m ago
Outlook Therapeutics (OTLK.US): The fourth quarter financial report for 2025 showed a revenue of -$91,787, compared to $0 previously, and an expected value of $5.955 million. Earnings per share were -$0.19, compared to -$0.94 previously, and an expected value of -$0.24.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.